Haleon HLN
NYSE HLN
$9.85 -0.02 (-0.20%)
At close: Aug 20, 2026 · 10:53 AM UTC

Haleon (HLN) Non-Current Deferred Tax Liability (2021 - 2026)

Haleon's (HLN) quarterly Non-Current Deferred Tax Liability came in at -$4.4 billion in Q2 2026, down 2.22% on a QoQ basis from -$4.3 billion in Q4 2025.

Haleon (HLN) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at -$4.4 billion in Q2 2026.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to -$4.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.4 billion (changed N/A YoY) and the FY2025 annual result came in at -$4.3 billion, down 199.99% from the prior year.
  • Non-Current Deferred Tax Liability retreated to -$4.4 billion in Q2 2026, from -$4.3 billion in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.3 billion in Q4 2023 to a low of -$4.6 billion in Q2 2022.
  • A 5-year average of -$1.1 billion and a median of -$4.3 billion in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability rose 6.5% — and 2025, when it sank 200.31%.
  • Tracing HLN's Non-Current Deferred Tax Liability over 5 years: stood at $4.2 billion in 2022, then rose by 2.47% to $4.3 billion in 2023, then retreated by 0.56% to $4.3 billion in 2024, then slumped by 200.31% to -$4.3 billion in 2025, then retreated by 2.22% to -$4.4 billion in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at -$4.4 billion (Q2 2026), -$4.3 billion (Q4 2025), and $4.3 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.76 Bn 42.79 Bn -
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn -
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.41 Bn
Jun 30, 2026 -4.41 Bn
Dec 31, 2025 -4.32 Bn
Dec 31, 2025 -4.32 Bn
Dec 31, 2024 4.30 Bn
Dec 31, 2024 4.30 Bn
Jun 30, 2024 -4.22 Bn
Jun 30, 2024 -4.22 Bn
Dec 31, 2023 4.33 Bn
Dec 31, 2023 4.33 Bn
Jun 30, 2023 -4.30 Bn
Jun 30, 2023 -4.30 Bn
Dec 31, 2022 4.22 Bn
Dec 31, 2022 4.22 Bn
Jun 30, 2022 -4.60 Bn
Jun 30, 2022 -4.60 Bn
Dec 31, 2021 4.53 Bn
Dec 31, 2021 4.53 Bn